| View |
|
DRP-7138-15
|
Ceftriaxone (as sodium)
|
Axonex
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial
|
Zeiss Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 October 2022
|
31 March 2027
|
| View |
|
DRP-9359-02
|
Rocuronium bromide
|
Rocumed
|
10 mg/mL (50 mg/5 mL)
|
Solution for Injection (IV)
|
Muscle Relaxant
|
Maiva Pharma Private Limited
|
India
|
CLIDP Conversion
|
03 October 2022
|
04 December 2025
|
| View |
|
DRP-9390-06
|
Telmisartan
|
Telminex-40
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Ltd..
|
India
|
CLIDP Conversion
|
03 October 2022
|
02 March 2026
|
| View |
|
DRP-9391-04
|
Telmisartan
|
Telminex-80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
03 October 2022
|
02 March 2026
|
| View |
|
DRP-10205-01
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
Gleezinc+D
|
500 mg (equivalent to 562.50 mg Sodium Ascorbate)/ 400 IU/ 20 mg (equivalent to 54.90 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamins/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
06 August 2026
|
| View |
|
DRP-10890-03
|
Cefepime (as hydrochloride) + Sulbactam (as sodium)
|
Quatam
|
1 g/500 mg
|
Powder for Injection (I.M./I.V)
|
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor
|
Swiss Parenterals Ltd.
|
India
|
CLIDP Conversion
|
03 October 2022
|
14 December 2026
|
| View |
|
DRP-12392-03
|
Cefalexin (as monohydrate)
|
Regilexin
|
100 mg/mL
|
Powder for Suspension for Oral Drops
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
21 July 2027
|
| View |
|
DRP-12407-03
|
Cefalexin (as monohydrate)
|
Ceplex
|
125 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporin)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
21 July 2027
|
| View |
|
DRP-12456-01
|
Vancomycin (as Hydrochloride)
|
Vancocent
|
1 g
|
Lyophilized Powder for I.V. Infusion
|
Antibacterial (Glycopeptide)
|
United Biotech Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 October 2022
|
10 August 2027
|
| View |
|
DRP-12608-01
|
Ascorbic Acid
|
Sano Cee
|
500 mg
|
Tablet (equivalent to 562.43 mg Sodium Ascorbate)
|
Vitamin
|
Hong Zhong Biotechnology Co., Ltd.
|
Taiwan
|
CLIDP Conversion
|
03 October 2022
|
30 September 2026
|
| View |
|
DRP-12754
|
Omeprazole (as Sodium)
|
None
|
20 mg
|
Lyophilized Powder for Intravenous Injection/Infusion
|
-
|
Shandong Yuxin Pharmaceutical Co., Ltd
|
China
|
PCPR Conversion
|
03 October 2022
|
25 April 2027
|
| View |
|
DRP-12757
|
Omeprazole (as Sodium)
|
None
|
40 mg
|
Lyophilized Powder for Intravenous Injection/Infusion
|
-
|
Shandong Yuxin Pharmaceuitcal Co., Ltd
|
China
|
PCPR Conversion
|
03 October 2022
|
25 April 2027
|
| View |
|
DRP-12745
|
Sugammadex (As Sodium)
|
None
|
100 mg/mL (200 mg/2mL)
|
Solution For Injection (I.V.)
|
Antidote
|
USV Private Limited
|
India
|
Automatic Renewal
|
30 September 2022
|
25 July 2027
|
| View |
|
DRP-2484-05
|
Isoxsuprine hydrochloride
|
Isoxel
|
10 mg
|
Tablet
|
Tocolytic
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
29 September 2022
|
13 April 2025
|
| View |
|
DRP-6027-03
|
Omeprazole
|
Malprazole Plus
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
29 September 2022
|
27 February 2025
|
| View |
|
DRP-6507-02
|
Metformin Hydrochloride
|
None
|
500 mg
|
Extended-Release Tablet
|
Oral Hypoglycemic (Biguanide)
|
Merck, Inc.
|
France
|
Initial (Variation)
|
01 August 2024
|
31 July 2029
|
| View |
|
DRP-7357-05
|
Cefixime (as trihydrate)
|
Fixicon
|
400 mg
|
Dispersible Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd
|
India
|
Renewal
|
16 March 2024
|
26 February 2029
|
| View |
|
DRP-7374-01
|
Esomeprazole (as magnesium)
|
Sazol
|
20 mg
|
Delayed-Release Tablet
|
-
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
29 September 2022
|
12 August 2025
|
| View |
DRP-8462-01_PI_01.pdf
|
DRP-8462-01
|
Salbutamol
|
Aero-vent
|
4 mg/5 mL
|
Syrup
|
Antiasthma
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 May 2023
|
31 July 2028
|
| View |
|
DRP-10631-02
|
Vancomycin (as hydrochloride)
|
Afree-Vanco 1000
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Glycopeptide)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
29 September 2022
|
10 November 2026
|